BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, July 29, 2026
Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
Musculoskeletal RSS Feed RSS

CleveXel and Dynamix to develop new treatment for rheumatoid arthritis

Nov. 27, 2013

Sanofi and Regeneron report phase III data for sarilumab in rheumatoid arthritis

Nov. 25, 2013

Horizon Pharma to acquire U.S. rights to Vimovo

Nov. 20, 2013

Results from phase IIIb study of Xiaflex for Dupuytren's contracture with multiple palpable cords

Nov. 19, 2013

Lupin discloses novel CRAC modulators

Nov. 19, 2013

A comparison of systemic and macrophage receptor-targeted delivery of an anti-inflammatory drug

Nov. 19, 2013

Ajinomoto patents novel integrin alpha4beta7 receptor antagonists

Nov. 18, 2013

Japanese researchers present novel Toll-like receptor antagonists

Nov. 15, 2013

MiR-155 antagomir ameliorates experimental lupus pulmonary hemorrhage

Nov. 14, 2013

ChemoCentryx describes novel small-molecule inhibitors of CCR1 and CCR6

Nov. 13, 2013
Previous 1 2 … 185 186 187 188 189 190 191 192 193 … 608 609 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 29, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 28, 2026
  • Illustration of dopamine signaling in the brain

    New schizophrenia targets challenge trial design

    BioWorld
    The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
  • Regulatory actions for July 27, 2026

    BioWorld
    Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...
  • Other news to note for July 27, 2026

    BioWorld
    Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Abbvie, Genmab, Merck, Par, Thyora.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing